Stock Trim Losses -...
Health Care: Drugs
Aegerion Pharmaceuticals Inc. (AEGR: NASDAQ)
$60.96 2.71 | 4.65%
05/23/13 - 04:00 PM ET
542.29K / 640.10K
Vol / Avg. Vol:57.52 / 58.25
Open / Prev. Close:55.76 - 61.23
Today's Range:12.87 - 63.72
52 Wk Range:136.49%
Performance YTD:TheStreet Rating:
Portfolios with AEGR
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Rising On Unusual Vo...
- ContributorDrugs Facing FDA Approval i...
- ContributorStocks Rising On Unusal Vol...
- ContributorStocks With Big Insider Buy...
Latest AEGR Headlines from TheStreet
- Aegerion Stock Falls On Unusually High Volume (AEGR) 05.17.13 | 12:05 pm
- 4 Stocks Improving Performance Of The Health Care Sector 05.16.13 | 01:05 pm
- Biotech Is Where the Bucks Are 05.09.13 | 06:05 am
- Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program 05.03.13 | 04:05 pm
- Aegerion Pharmaceuticals Announces Presentation At The Bank Of America Merrill Lynch 2013 Healthcare Conference 05.03.13 | 08:05 am
- Aegerion Pharmaceuticals Announces First-Quarter 2013 Financial Results 04.30.13 | 07:04 am
- Anne VanLent Appointed To Aegerion Pharmaceuticals' Board Of Directors 04.29.13 | 07:04 am
- Aegerion Pharmaceuticals Announces Presentation At The Needham Healthcare Conference 04.25.13 | 04:04 pm
- Aegerion Pharmaceuticals To Announce First Quarter 2013 Financial Results On Tuesday, April 30 04.16.13 | 08:04 am
- Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program 04.03.13 | 04:04 pm
Press Releases for AEGR
- Insmed Appoints Will Lewis As President And Chief Executive Officer - PR Newswire 09.11.12 | 08:09 am
- Aegerion Pharmaceuticals Chief Executive Officer Marc D. Beer (Video: Business Wire) - Business Wire 09.29.11 | 08:09 am
Partner Headlines for AEGR
- Insider Buying Trends: Are These Cash Rich Companies Ready To Rally? - Seeking Alpha 03.15.13 | 09:03 am
- UPDATE: Canaccord Genuity Raises PT to $44 on Aegerion Pharmaceuticals on Encouraging Sales Data - Benzinga 03.07.13 | 01:03 pm
- UPDATE: Deutsche Bank Raises PT on Aegerion Pharmaceuticals on Strong Juxtapid Uptake - Benzinga 03.06.13 | 01:03 pm
- Pre-Market Earnings Report for March 6, 2013 : SPLS, BF/B, AEO, TFM, BIG, AEGR, HOV, WD, TRK, QRE, WILN, MFB - NASDAQ 03.05.13 | 09:03 pm
- Calendar Spreads On Intuitive Surgical, Riverbed Technology And Sandisk - Seeking Alpha 10.19.12 | 09:10 am
- Benzinga Mid-Day Market Update - Benzinga 10.17.12 | 12:10 pm
- 5 Pharmaceutical Companies With EMA Catalysts During The Next 3 - 12 Months - Part II - Seeking Alpha 09.02.12 | 08:09 am
- Aegerion Pharmaceuticals Announces Date of FDA Advisory Committee Review of Lomitapide NDA - Benzinga 08.14.12 | 09:08 am
- 16 Healthcare Stocks Deeply Discounted From Target Price - Seeking Alpha 01.12.12 | 09:01 am
- UPDATE: Aegerion Pharmaceuticals Files Registration Statement for Proposed Offering of 4.25M Shares - Benzinga 06.16.11 | 04:06 pm
